Protective effect of β-glucan against systemic Streptococcus pneumoniae infection in mice

FEMS Immunology and Medical Microbiology

Volumn 27, Issue 2, 2000, Pages 111-116

  Hetland, Geir ^a   Ohno, Naohito ^b   Aaberge, Ingeborg S ^a   Løvik, Martinus ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

1,3 D Glucan; Antimicrobial effect; Streptococcus pneumoniae

Indexed keywords

BETA 1,3 GLUCAN; SCLEROTINIA SCLEROTIORUM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, BACTERIAL; BACTEREMIA; BETA-GLUCANS; COLONY COUNT, MICROBIAL; FEMALE; GLUCANS; HUMANS; MICE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE;

EID: 0033964815     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00172-8     Document Type: Article

References (27)

1. Riggi S., Di Luzio N.R. Identification of a RE stimulating agent in zymosan. Am. J. Physiol. 200:1961;297-300.
2. Bøgwald J., Gouda I., Hoffmann J., Larm O., Larsson R., Seljelid R. Stimulatory effect of immobilized glucans on macrophages in vitro. Scand. J. Immunol. 20:1984;355-360.
3. Kokoshis P.L., Williams D.L., Cook J.A., Di Luzio N.R. Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science. 199:1978;1340-1342.
4. Reynolds J.A., Kastello M.D., Harrington D.G., Crabbs C.L., Peters C.J., Jemski J.V., Scott G.H., Di Luzio N.R. Glucan-induced enhancement of host resistance to selected infectious diseases. Infect. Immun. 30:1980;51-57.
5. Cook J.A., Holbrook T.W., Dougherty W.J. Protective effect of glucan against visceral leishmaniasis in hamsters. Infect. Immun. 37:1982;1261-1269.
6. Williams D.L., Cook J.A., Hoffmann E.O., Di Luzio N.R. Protective effect of glucan in experimentally induced candidiasis. J. Reticuloendothel. Soc. 23:1978;479-490.
7. Hetland G., Løvik M., Wiker H.G. Protective effect of β-glucan against Mycobacterium bovis, BCG infection in Balb/c mice. Scand. J. Immunol. 47:1998;548-553.
8. Morikawa K., Takeda R., Yamazaki M., Mizuno D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear β-1,3-D-glucan and other immunomodulators in murine cells. Cancer Res. 45:1985;1496-1501.
9. Di Luzio, N.R., McNamee, R., Jones, E., Cook, J.A. and Hoffmann, E.O. (1976) The employment of glucan and glucan activated macrophages in the enhancement of host resistance to malignancies in experimental animals. In: The Macrophage in Neoplasia (Fink, M.A., Ed.), pp. 181-198. Academic Press, New York.
10. Amino M., Noguchi R., Yata J.etal. Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients. Jpn. J. Cancer Chemother. 10:1983;2000-2006.
11. Czop J.K., Austen K.F. Properties of glucans that activate the human alternative complement pathway and interact with the human monocyte β-glucan receptor. J. Immunol. 133:1985;3388-3393.
12. Vetvicka V., Thornton B.P., Ross G.D. Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 98:1996;50-61.
13. Ohno N., Kurachi K., Yadomae T. Antitumor activity of highly branched (1→3)beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395. J. Pharmacobiodyn. 10:1987;478-486.
14. Ohno N., Suzuki I., Yadomae T. Structure and antitumor activity of a beta-1,3-glucan isolated from the culture filtrate of Sclerotina sclerotiorum IFO 9396. Chem. Pharm. Bull. 34:1986;1362-1365.
15. Ohno N., Yadomae T. Two different conformations of the antitumor beta-D-glucan produced by Sclerotinia sclerotiorum IFO 9395. Carbohydr. Res. 159:1987;293-302.
16. Suda M., Ohno N., Adachi Y., Yadomae T. Modulation of the antitumor effect and tissue distribution of highly branched (1→3)-β-D-glucan, SSG, by carrageenan. Biol. Pharm. Bull. 18:1995;772-775.
17. Taguchi T., Furue H., Kimura T., Kondo T., Hattori T., Ogawa N. Clinical efficacy of lentinan on neoplastic diseases. Adv. Exp. Med. Biol. Biother. 166:1983;181-187.
18. Henrichsen J. The pneumococcal typing system and pneumococcal surveillance. J. Infect. 1:(Suppl. 2):1979;31-37.
19. Aaberge I.S., Eng J., Lermark G., Løvik M. Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb. Pathog. 18:1995;141-152.
20. Aaberge I.S., Michaelsen T.E., Rolstad A.K., Groeng E.-C., Solberg P., Løvik M. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection. Infect. Immun. 60:1992;4146-4153.
21. Nathan C.F. Secretory products of macrophages. J. Clin. Invest. 79:1987;319-326.
22. Sakurai T., Ohno N., Yadomae T. Changes in immune mediators in mouse lung produced by administration of soluble (1→3)-β-D-glucan. Biol. Pharm. Bull. 17:1994;617-622.
23. Suzuki I.K., Hashimoto K., Oikawa S., Sato K., Osawa M., Yadomae T. Antitumor and immunomodulating activities of a β-glucan obtained from liquid-cultured Grifola frondosa. Chem. Pharm. Bull. (Tokyo). 37:1989;410-413.
24. Soltys J., Quinn M.T. Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with β-(1,6)-branched β-(1,3)-glucan. Infect. Immun. 67:1999;244-252.
25. O'Neal B.J., McDonald J.C. The risk of sepsis in the asplenic adult. Ann. Surg. 194:1981;775-778.
26. Aaberge I.S., Løvik M. The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: the effect of re-immunization with pneumococcal antigens. APMIS. 104:1996;307-317.
27. Suda M., Ohno N., Adachi Y., Yadomae T. Tissue distribution of intraperitoneally administered (1→3)-β-D-glucan (SSG), a highly branched antitumor glucan, in mice. J. Pharmacobiodyn. 15:1992;417-426.